Corvus Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $84.8M | $45.1M |
| FY2018 | — | $110.3M | $39.2M |
| FY2019 | — | $71.1M | $5.2M |
| FY2020 | — | $72.1M | $16.5M |
| FY2021 | — | $97.2M | $63.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $84.8M | $45.1M |
| FY2018 | — | $110.3M | $39.2M |
| FY2019 | — | $71.1M | $5.2M |
| FY2020 | — | $72.1M | $16.5M |
| FY2021 | — | $97.2M | $63.5M |